- GE shares surge 17% after Danaher agrees to buy biopharma business for $21.4 billion CNBC
- GE to sell BioPharma business to Danaher for $21.4B Fox Business
- GE to Sell Its Biotech Business to Danaher for $21 Billion The Wall Street Journal
- GE's stock soars after deal to sell biopharma business to Danaher for $21.4 billion MarketWatch
- General Electric Sells Biopharma Unit for $21.4 Billion as Culp Unwind Continues TheStreet.com
- View full coverage on Google News
Monday, February 25, 2019
GE shares surge 17% after Danaher agrees to buy biopharma business for $21.4 billion - CNBC
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment